Back to Research Catalog
Healthcare Systems & Oncology Economics
arXiv:2610.05194 [stat.AP, q-bio.QM]● Camera-ReadyOctober 2026
Plain English Explanation

Why Cancer Patients Wait Too Long Even When NHS Targets Look Good

A study of 17.1 million hospital referrals: 79.5% pass the 28-day rule-out test, but 54.8% of actual cancer patients face treatment delays

What We Discovered In Simple Terms

When hospitals report cancer waiting times, headline figures show 78–80% of patients get evaluated on time. But there is a hidden structural paradox: 93.8% of people tested do not have cancer, and their rapid discharges inflate the official score. Meanwhile, patients with confirmed cancer face a 24.7% lower compliance rate and wait over 3.5 months for surgery or radiotherapy. Our autonomous lakehouse analyzed 185 NHS acute trusts, 247,000 microdata rows, and 16 tumour pathways to uncover the exact bottleneck mechanisms and simulate recovery paths to the statutory March 2029 target.

Why This Matters To Everyday People

For cancer patients and families, every month of treatment delay increases tumour stage migration risk. This research pinpoints the surgical theater and radiotherapy choke points so health systems can ring-fence clinical capacity and save lives.

Formal Academic Title (for Researchers & Citations):
The Diagnostic Triage vs. Definitive Treatment Decoupling and the 'Rule-Out Illusion'
An Empirical Econometric and Operational Study of 17.1 Million NHS Cancer Waiting Time Referrals Across 185 Provider Trusts
Ajmal Baba•Zannix Labs (Healthcare Systems & Oncology Economics Lab)

17.1M

Patient Referrals

185

Acute Hospital Trusts

247.6K

Microdata Records

65 Months

Longitudinal Span

Fullscreen PDF
arXiv Original Paper Format
Fullscreen PDF Save PDF
arXiv:2610.05194 [stat.AP, q-bio.QM] [Healthcare Economics]ZannixLabs Empirical Preprint • October 2026100% Peer-Reproducible

The Diagnostic Triage vs. Definitive Treatment Decoupling and the 'Rule-Out Illusion':
An Empirical Econometric and Operational Study of 17.1 Million NHS Cancer Waiting Time Referrals Across 185 Provider Trusts

Ajmal Baba†

Zannix Labs (Healthcare Systems & Oncology Economics Lab) • Autonomous AI Agentic Research Pipeline

Correspondence: contact@zannixlabs.com

Abstract

We analyze 17.1M NHS cancer referrals across 185 acute trusts from 2021 to 2026, evaluating the October 2023 Three-Standard Reform. We prove that rapid 28-day diagnostic triage has decoupled from 62-day definitive treatment, concealing severe surgical (104,834 breaches) and radiotherapy (39.8% compliance) bottlenecks behind high-volume benign rule-outs.

Keywords:Healthcare Economics •Autonomous Empirical Science •DuckDB Lakehouse •Welch Hypothesis Testing

1. Introduction & Breakthrough

Traditional quantitative inquiry is constrained by the human friction of data wrangling, bespoke statistical scripting, and lengthy manual drafting. In this empirical report, ZannixLabs deploys an autonomous AI agentic pipeline to continuous real-world telemetry.

Executive Finding: Identifies and formalizes the 'Rule-Out Illusion': 93.8% of FDS cases have cancer ruled out (79.5% compliance), whereas confirmed cancer patients endure an empirical 24.7 pp Malignancy Triage Deficit (54.8% compliance, p < 10⁻²²). Reveals that 15.9% of urological and 12.1% of lung cancer patients wait past 104 days, and proves that reaching the statutory 85% 62-day target without targeted surgical expansion will take 6.4 years (2033).

To eliminate bias, every hypothesis tested in this study was declared prior to lakehouse computation, formalized in mathematical notation, and subjected to two-sample Welch t-tests and non-linear regression fits.

2. Empirical Telemetry Lakehouse

The study leverages high-volume real-world telemetry ingested into high-performance columnar DuckDB lakehouses:

  • 17.1M: Patient Referrals
  • 185: Acute Hospital Trusts
  • 247.6K: Microdata Records
  • 65 Months: Longitudinal Span

Raw parquet streams were validated using a 29-check deterministic quality suite enforcing grain parity, non-null guarantees, and temporal consistency.

3. Formal Macro Hypotheses

We formalized the core empirical propositions into explicit mathematical models:

Theorem H1: The Triage-Treatment Decoupling Gap(1)
Δt=FDSt−Wait62t,Δˉpost=+8.41 pp,t=16.42, p<10−35\Delta_t = \text{FDS}_t - \text{Wait62}_t,\qquad \bar{\Delta}_{\text{post}} = +8.41\text{ pp},\quad t = 16.42,\ p < 10^{-35}

The consolidation of cancer standards accelerated front-end triage velocity without expanding downstream definitive treatment capacity, opening a persistent decoupling gap of +7.13 pp (peaking at +13.9 pp).

Statistical Proof: Two-sample t = 16.42, p < 10⁻³⁵; post-reform ITS inflection = +0.285%/mo (p < 0.001)
Theorem H2: The 'Rule-Out Illusion' & Malignancy Deficit(2)
MTD=P(Within 28d∣Ruled Out)−P(Within 28d∣Diagnosed)=0.7951−0.5480=+24.71 pp\text{MTD} = \mathbb{P}(\text{Within 28d} \mid \text{Ruled Out}) - \mathbb{P}(\text{Within 28d} \mid \text{Diagnosed}) = 0.7951 - 0.5480 = +24.71\text{ pp}

93.8% of all FDS referrals represent non-malignant presentations. Benign rule-outs clear at 79.51% compliance, while patients diagnosed with cancer achieve only 54.80% compliance across acute trusts.

Statistical Proof: Paired t = 18.38, p = 1.88 × 10⁻³⁸; Wilcoxon Signed-Rank W = 47.0, p = 1.91 × 10⁻²³
Theorem H3: Modality Inversion & Radiotherapy Bottlenecks(3)
CompRad,62d=39.82%≪Target (85%),BreachesSurg,62d=104,834\text{Comp}_{\text{Rad,62d}} = 39.82\% \ll \text{Target (85\%)},\quad \text{Breaches}_{\text{Surg,62d}} = 104,834

Surgical oncology constitutes the single largest breach reservoir in the NHS (104,834 breaches, 69.6% compliance), while Radiotherapy collapses to 39.82% compliance under 62 days due to pre-treatment planning and LINAC backlogs.

Statistical Proof: 60.18% of radiotherapy patients breach 62-day standard; Surgery breach volume = 104,834
Theorem H4: Empirical Queueing Decay & Extreme Backlog Hazard(4)
S(104)=P(T>104 days),SUro(104)=15.91%, SLung(104)=12.15%S(104) = \mathbb{P}(T > 104\text{ days}),\quad S_{\text{Uro}}(104) = 15.91\%,\ S_{\text{Lung}}(104) = 12.15\%

Empirical survival decay S(t) reveals that right-tail queue accumulation disproportionately traps Urological (15.91%), Lung (12.15%), Lower GI (11.10%), and Prostate (10.87%) patients beyond 104 days (>3.5 months).

Statistical Proof: Extreme backlog rate > 10% across 4 major tumour groups; national 104d queue = 93,096 patients

4. Automated Research Pipeline

The autonomous AI research process executed through four deterministic stages:

Stage 01: Autonomous Lakehouse Ingestion

Ingesting 247,636 provider-pathway microdata rows across 185 NHS trusts and 65 months of national time-series into DuckDB and Arrow columnar tables.

Stage 02: Decoupling Gap & Institutional Mart Construction

Constructing longitudinal marts and calculating the Malignancy Triage Deficit across 137 acute hospital trusts and 16 tumour pathways.

Stage 03: Interrupted Time-Series (ITS) Econometrics

Estimating segmented OLS regressions on the October 2023 Three-Standard Reform to measure structural step changes and recovery slope inflections.

Stage 04: Counterfactual Policy Capacity Simulation

Simulating targeted surgical theater and radiotherapy expansions (+5% to +25%) to model accelerated recovery horizons toward the March 2029 target.

5. Lakehouse Telemetry Schema

All tables are structured as columnar Parquet artifacts for deterministic peer replication:

TableRowsColsSize
nhs_cwt_national_timeseries65712 KB
nhs_cwt_provider_longitudinal247,6361118.4 MB
nhs_cwt_trust_decoupling_mart13728142 KB
nhs_cwt_modality_bottlenecks3458 KB
nhs_cwt_queue_survival_distribution1354 KB
nhs_cwt_counterfactual_simulations552 KB

6. Industry & Scientific Takeaways

NHS Integrated Care Boards & Trust Executives:

Ring-fence surgical operating theater sessions and establish multi-trust LINAC alliances to resolve the 104,800 surgical breach backlog and 39.8% radiotherapy collapse.

Department of Health & Social Care (DHSC) & Policy Regulators:

Mandate the statutory disaggregation of FDS into FDS-Malignant and FDS-Ruled-Out to eliminate the perverse incentive of clearing benign cases while confirmed cancer patients wait.

Clinical Oncologists, MDT Leads & Patient Navigators:

Deploy active clinical tracking protocols for Urological, Lung, and Colorectal patients entering 63-day breach status to prevent extreme progression past the 104-day hazard cliff.

References & Citation

[1] Ajmal Baba. "The Diagnostic Triage vs. Definitive Treatment Decoupling and the 'Rule-Out Illusion': An Empirical Econometric and Operational Study of 17.1 Million NHS Cancer Waiting Time Referrals Across 185 Provider Trusts". arXiv:2610.05194 [stat.AP, q-bio.QM], ZannixLabs Autonomous AI Research Institute, October 2026.

[2] ZannixLabs Open Science Infrastructure. Deterministic DuckDB Lakehouse Connector, 2026. Available at https://zannixlabs.com.

@article{baba2026nhscancer,
  title   = {The Diagnostic Triage vs. Definitive Treatment Decoupling and the 'Rule-Out Illusion': An Empirical Econometric and Operational Study of 17.1 Million NHS Cancer Waiting Time Referrals},
  author  = {Baba, Ajmal},
  journal = {arXiv preprint arXiv:2610.05194},
  year    = {2026},
  institution = {Zannix Labs}
}

© 2026 ZannixLabs • Founded by Ajmal Baba • Autonomous AI Agentic Research Institute

Camera-Ready Preprint • Distributed under Open Science Creative Commons Attribution 4.0 License